21 May 2013
Keywords: corixa, gsk, start, trial, tb, vaccine, usa-based
Article | 26 January 2004
USA-based immunotherapeutics developer Corixa and European drug major GlaxoSmithKline's biologicals units plan to initiate a US Phase I trial
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 January 2004
20 May 2013
© 2013 thepharmaletter.com